Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : BCYC    save search

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -2.71% H: 0.65% C: -1.25%

conference bicycle therapeutics
Bicycle Therapeutics to Participate in Upcoming Investor Conferences - February 28, 2024
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.92% H: 3.42% C: -1.37%

bicycle therapeutics
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-20 (Crawled : 23:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -1.78% H: 4.75% C: 2.67%

business year bicycle therapeutics financial results
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-07 (Crawled : 13:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 0.0% C: -3.4%

conference life bicycle sciences therapeutics
Bicycle Therapeutics to Host R&D Day on December 14
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 7.25% H: 5.93% C: -0.69%

day bicycle therapeutics
Bicycle Therapeutics to Participate in Upcoming Investor Conferences - October 30, 2023
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 4.32% C: 1.85%

bicycle therapeutics
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
Published: 2023-10-19 (Crawled : 12:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 7.68% C: -1.83%

bt8009 fda bicycle bladder cancer commercial program therapeutics
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director
Published: 2023-10-19 (Crawled : 09:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 7.68% C: -1.83%


Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
Published: 2023-09-11 (Crawled : 13:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 1.48% H: 8.94% C: 7.38%

bt8009 bicycle bladder cancer therapeutics
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-09-05 (Crawled : 20:00) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M twitter stocktwits trandingview |
Finance
| | O: 0.01% H: 0.0% C: 0.0%
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 2.67% C: -0.27%

conference bicycle global therapeutics
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-03 (Crawled : 13:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -1.17% H: 3.06% C: 1.09%

bicycle update therapeutics financial results
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2023-07-18 (Crawled : 14:20) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.81% C: -2.17%

bicycle offering therapeutics
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
Published: 2023-07-13 (Crawled : 08:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 2.32% H: 18.21% C: 16.61%

bicycle offering therapeutics
Global Constrained Peptide Drugs Market to 2040: Increasing Government and Private Funding Bolsters Growth
Published: 2023-06-26 (Crawled : 17:00) - prnewswire.com
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -1.03% H: 0.88% C: -2.52%
ALRN | $5.01 17.88% 15.17% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.16% H: 3.93% C: 2.29%

global funding growth market
Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
Published: 2023-06-23 (Crawled : 14:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -1.11% H: 3.0% C: -4.99%

bicycle therapeutics financial
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference - May 31, 2023
Published: 2023-05-31 (Crawled : 12:01) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 2.68% C: -0.5%

conference bicycle therapeutics
Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023
Published: 2023-05-11 (Crawled : 12:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 0.73% H: 1.7% C: -2.25%

bicycle preclinical therapeutics
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Published: 2023-05-10 (Crawled : 12:20) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: 4.78% H: 5.7% C: -0.3%

bicycle collaboration therapeutics
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
Published: 2023-05-04 (Crawled : 18:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -1.97% H: 1.68% C: -2.34%

bicycle cancer wholly research collaboration therapeutics
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-04 (Crawled : 12:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 700K twitter stocktwits trandingview |
Health Technology
| | O: -1.97% H: 1.68% C: -2.34%

bicycle update therapeutics financial results
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.